Showing results (171-180 of 277) with videos related to

Sort By:
Pageof 28
BMC Cancer|November 12, 2017
TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOPYalu Liu, Xiaogan Wang, Ning Ding, et al.
Hematological Oncology|September 26, 2021
Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysisMingxiao Lang, Youqin Feng, Xiangrui Meng, et al.
Annals of Hematology|September 7, 2016
Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndromeJing Jia, Yuqin Song, Ningjing Lin, et al.
BMC Public Health|June 7, 2025
The impact of only-child status on adolescent mental health: a multi-center cross-sectional study using propensity score matching in Western ChinaJinlong He, Yunling Zhong, Yuqin Song, et al.
Aging|November 3, 2022
Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK/T-cell lymphoma receiving sequential chemotherapy and radiationFei Qi, Wenyuan Zhou, Yan Xie, et al.
International Journal of Cancer|February 28, 2025
Pirtobrutinib in Chinese patients with relapsed or refractory B-cell malignancies: A single-arm, open-label, phase 2, multicenter trialYanyan Liu, Ningjing Lin, Shuhua Yi, et al.
BMC Medicine|March 8, 2024
Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trialYanfei Liu, Lingyan Ping, Yuqin Song, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 25, 2014
[Prognostic value of 18F-FDG PET-CT in Hodgkin lymphoma]Zhitao Ying, Xuejuan Wang, Yuqin Song, et al.
Cancer Cell International|January 21, 2014
Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphomaZhiying Fu, Jun Zhu, Wen Zheng, et al.
Cryobiology|July 30, 2020
The clinical outcomes of fresh versus cryopreserved CD19-directed chimeric antigen receptor T cells in non-Hodgkin lymphoma patientsTong Su, Zhitao Ying, Xin-An Lu, et al.
Pageof 28